Biopharm Intl Webinar – Are You Seeing The Whole Picture?

In this webinar, we introduce how Backgrounded Membrane Imaging (BMI) can be used to analyze subvisible particles (SVP), an indicator of drug efficacy and safety. BMI is a fully automated form of USP <788> membrane microscopy available on the Horizon instrument that delivers 96-well automation and rapidly generates accurate particle counts and sizing data in a low volume, high throughput format. With BMI, SVP analysis can be incorporated at any stage of biologic development – from candidate selection to formulation screening, process development, and analytical – providing key insights that reduce drug development risk and time to market.